deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01825330

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Effect of NeuroAD, Combined TMS Stimulation and Cognitive Training, on the Cognitive Function of Mild to Moderate Alzheimer Patients

Sponsor: Neuronix Ltd

Conditions Alzheimer's Disease
Interventions TMS and cognitive stimulation sham
Updated 6 times since 2017 Last updated: Mar 29, 2016 Started: Oct 31, 2013 Primary completion: Jan 31, 2016 Completion: Mar 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Alzheimer's Disease, this trial is completed. The trial is conducted by Neuronix Ltd and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Feb 2017 — Jun 2018 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Neuronix Ltd
Data source: Neuronix Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations